Highlights Archive

AMLo Biosciences is a BIVDA member company, and SME, which has received media attention over some very interesting research published from Newcastle University. The company has developed a test which reliably predicts the spread or return of the most deadly form of skin cancer. The team at Newcastle University, led by Professor Penny Lovat, in association with AMLo Biosciences have…

Cervical screenings in Wales will now be conducted every 5 years, up from the previous 3-year cycle. The change came after recommendations from the UK National Screening Committee due to the recent success of HPV testing. Consultant in public health for Cervical Screening Wales, Heather Lewis said: "The HPV test we now use in Wales is more effective at identifying…

The architecture and engineering firm BDP, the company behind many of the Nightingale Hospitals, has repurposed materials from the dismantled surge hospitals to create the first of 40 new diagnostic centres which are to open in England. This follows the Government’s announcement in October that £350 million would be pledged to the building of diagnostic centres, with the hope of…

A North East-based lab is celebrating one year since it was set up to accelerate the development of the next generation of virus testing. The lab, based at The Biosphere in Newcastle Helix and hosted by The Newcastle upon Tyne Hospitals NHS Foundation Trust, brings together a partnership of local universities, healthcare organisations and industry, with the aim of bringing…

A recruitment process for a new Patient Safety Commissioner in England is set to begin, with a job specification already published. The creation of the post follows on from recommendations made by the Baroness Cumberlege in a major medicine and medical device safety report. The ‘First do no harm’ report was a review of independent medicines and medical devices, including…

What’s been said in Parliament this week? In a debate on UK Productivity, Bill Esterson MP (Lab) asked why the Government were buying tests from China rather than the UK. He went on to accuse the MHRA of delaying approval to British tests, leading British companies unable to sell their tests at home but able to sell them abroad. Kwasi…